Chapter Twelve — Medication, Measurement, and Working with Your Clinician
Chapter Twelve.
Medication, Measurement, and Working with Your Clinician.
Chapter Twelve — new in this edition
The emotional part of ADHD is the part most often left out of the appointment. This chapter is about putting it back in.
"Bring your data, not your apology. You are allowed to ask for help precisely."
Four numbers, brought in —
the room finally believes
what the body knew.
Nothing in this chapter is medical advice, and no book can be. What it can do is prepare you for a conversation that is frequently rushed, and give a clinician a structure for the part of the presentation that the diagnostic criteria do not name.
What the medication evidence says, at a high level.
A large network meta-analysis comparing ADHD medications across children, adolescents, and adults synthesised efficacy and tolerability from randomised trials, and remains the standard reference for how these agents compare. Consensus guidance for adult diagnosis and treatment is summarised in the updated European Consensus Statement, and the World Federation's international consensus statement provides 208 evidence-based conclusions with sources. Those three documents are a reasonable basis for asking your prescriber informed questions.
On the emotional dimension specifically, the picture is more limited and worth stating precisely. Reviews of emotion regulation in adult ADHD note that pharmacological and psychological treatments both appear to influence emotional difficulties, but that the studies are few, heterogeneous in their measures, and rarely designed with emotion dysregulation as the primary outcome. In practice this means: medication may reduce emotional reactivity for you, or may not, and it may reduce it partly by reducing the number of daily failures that generate rejection events in the first place. That is a real mechanism and worth naming with your prescriber.
Bringing rejection sensitivity into the appointment.
Because RSD is not a diagnostic term, saying "I have RSD" can land badly with a clinician who has not encountered it. A more reliable route is description plus data, which is exactly what the worksheets produce. Bring: how often, how fast, how long, what it stops you doing. For example — "three or four times a week; it arrives within seconds of a message; it takes me two to three hours to be able to work again; last month I did not apply for two jobs because of it." That is a clinical presentation. It cannot be dismissed as a label from the internet.
Worksheet 12.1 is a single page designed to be handed over at an appointment. Worksheet 12.3 is a medication-and-mood tracker for the first eight weeks of any change. Worksheet 12.6 is a list of questions to ask a prescriber.
Combining treatment, and what to expect.
For most adults, the evidence favours combination over either alone: medication for core symptoms where appropriate, plus psychological treatment for the skills, avoidance, and self-concept that medication does not touch. CBT has meta-analytic support in adults with ADHD, including in those already medicated with residual symptoms, mindfulness-based programmes have randomised support, and psychosocial treatment gains are maintained at follow-up in meta-analytic review.
A word about expectations, offered honestly. Nothing in this book, and nothing in the literature it cites, will make you a person who does not feel rejection intensely. The realistic outcome — and it is a large one — is a longer gap between the feeling and the action, fewer irreversible decisions, faster recovery, and a self-account that no longer treats a hard afternoon as evidence of your worth.
Evidence at a glance.
Well supported: Comparative medication efficacy and tolerability across the lifespan; consensus guidance.
Well supported: Combined psychological and pharmacological treatment for adults.
Emerging: Effects of treatment specifically on emotion dysregulation — few studies, heterogeneous measures.
Clinical model: The indirect route — fewer daily failures, therefore fewer rejection events — is a plausible mechanism, not a tested one.
Bringing This to Your Clinician.
At a medication review, it's worth raising the emotional side directly, even if it feels off-topic: "here's what happened this month when someone criticised me." That single sentence surfaces more than a symptom checklist, and clinicians are used to being asked for the extra thirty seconds it takes.